Cargando…

Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients

BACKGROUND: Increasing evidence states that the plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels and apolipoprotein particles are regarded as the risk maker for cardiovascular heart disease. Nevertheless, the issue about whether Lp-PLA2 is associated with apolipoprotein particles in i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Yang, Tang, Shengxing, Cao, Yuhan, Fu, Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532362/ https://www.ncbi.nlm.nih.gov/pubmed/33029257 http://dx.doi.org/10.1155/2020/8818358

Ejemplares similares

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021)

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
por: Cen, Jin-Ming, et al.
Publicado: (2015)

The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
por: Tian, Li, et al.
Publicado: (2011)

The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients
por: Ling, Yang, et al.
Publicado: (2021)

The Relationship Between Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children With Kawasaki Disease
por: Cheng, Zhenli, et al.
Publicado: (2022)

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
por: Saleheen, Danish, et al.
Publicado: (2017)

Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults
por: Haslam, Danielle E, et al.
Publicado: (2022)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
por: Lin, Yahui, et al.
Publicado: (2022)

Apolipoprotein CIII regulates lipoprotein-associated phospholipase A(2) expression via the MAPK and NFκB pathways
por: Han, Xiaolei, et al.
Publicado: (2015)

Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts
por: Laschkolnig, Anja, et al.
Publicado: (2014)

Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A(2) and YKL-40
por: Zhang, Hui, et al.
Publicado: (2018)

Expression of B2 Receptor on Circulating CD34-Positive Cells and Outcomes of Myocardial Infarction
por: Fu, Cong, et al.
Publicado: (2019)

Blocking the A(2B) adenosine receptor alleviates myocardial damage by inhibiting spleen-derived MDSC mobilisation after acute myocardial infarction
por: Yu, Zongying, et al.
Publicado: (2022)

The Relationship between Red Cell Distribution Width and Residual SYNTAX Scores in ST-Segment Elevation Myocardial Infarction Patients after Percutaneous Coronary Intervention
por: Ling, Yang, et al.
Publicado: (2021)

The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
por: Tian, Li, et al.
Publicado: (2010)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
por: Shui, Xing, et al.
Publicado: (2023)

Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease
por: Ohwada, Takayuki, et al.
Publicado: (2019)

Relationship of Placental and Serum Lipoprotein-Associated Phospholipase A2 Levels with Hypertensive Disorders of Pregnancy
por: Wang, Jing, et al.
Publicado: (2022)

Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment
por: Barekatain, Majid, et al.
Publicado: (2014)

Lipoprotein‐Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
por: Wallentin, Lars, et al.
Publicado: (2016)

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
por: Maiolino, Giuseppe, et al.
Publicado: (2012)

Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers
por: Ostadal, Petr, et al.
Publicado: (2012)

Low-density lipoprotein concentration in the normal left coronary artery tree
por: Soulis, Johannes V, et al.
Publicado: (2008)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
por: Chan, Dick C., et al.
Publicado: (2019)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2014)

Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease
por: Kimak, Elżbieta, et al.
Publicado: (2018)

Relationship between non–high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
por: Li, Ya, et al.
Publicado: (2020)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Correlation Between Body Fat Distribution, Plasma Lipids and Apolipoproteins with the Severity of Coronary Involvement in Patients with Stable Angina
por: Mazaheri, Shahram, et al.
Publicado: (2011)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease
por: Bahri, Raoudha, et al.
Publicado: (2008)

Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
por: Li, Yan-hong, et al.
Publicado: (2014)

Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease
por: Dai, Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t4dr3q62ev6u0jfkqo2huoi6nc